{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T09:23:38Z","timestamp":1649064218514},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T00:00:00Z","timestamp":1494460800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00108-017-0239-7","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T19:40:56Z","timestamp":1494531656000},"page":"556-567","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Klug-entscheiden-Empfehlungen in der Kardiologie"],"prefix":"10.1007","volume":"58","author":[{"given":"K.","family":"Werdan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Baldus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Nixdorff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-H.","family":"Kuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Katus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,11]]},"reference":[{"issue":"6","key":"239_CR1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00108-016-0062-6","volume":"57","author":"G Hasenfu\u00df","year":"2016","unstructured":"Hasenfu\u00df G, M\u00e4rker-Hermann E, Hallek M, F\u00f6lsch UR (2016) Klug entscheiden in der Inneren Medizin. Internist 57(6):521\u2013526","journal-title":"Internist"},{"issue":"27-28","key":"239_CR2","first-page":"A1312","volume":"113","author":"S Baldus","year":"2016","unstructured":"Baldus S, Werdan K, Levenson B, Kuck KH, Bauersachs J, Frey N, Halle M, Hausleiter J, Massberg S, Nixdorff, Stellbrink C (2016) KLUG ENTSCHEIDEN\u2026in der Kardiologie. Dtsch Arztebl 113(27-28):A1312\u2013A1315 (Das Leser-Forum: 113(31-32):A-1446\/B-1222\/C-1202 und 113(35-36):A-1544\/B-1301)","journal-title":"Dtsch Arztebl"},{"issue":"7","key":"239_CR3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMp1314965","volume":"370","author":"NE Morden","year":"2014","unstructured":"Morden NE, Colla CH, Sequist TD, Rosenthal MB (2014) Choosing wisely \u2013 the politics and economics of labeling low-value services. N\u00a0Engl J Med 370(7):589\u2013592","journal-title":"N Engl J Med"},{"key":"239_CR4","volume-title":"Ad hoc Kommission \u201eGemeinsam Klug Entscheiden\u201c. Manual Entwicklung von Empfehlungen im Rahmen der Initiative Gemeinsam Klug Entscheiden. Version 1.0 (Konsultationsfassung)","author":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)","year":"2015","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2015) Ad hoc Kommission \u201eGemeinsam Klug Entscheiden\u201c. Manual Entwicklung von Empfehlungen im Rahmen der Initiative Gemeinsam Klug Entscheiden. Version 1.0 (Konsultationsfassung). \n                        http:\/\/www.awmf.org\/medizin-versorgung\/gemeinsam-klug-entscheiden.html\n                        \n                    . Zugegriffen: 03.05.2017"},{"issue":"4","key":"239_CR5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1378\/chest.15-1622","volume":"149","author":"L Fauchier","year":"2016","unstructured":"Fauchier L, Lecoq C, Clementy N et\u00a0al (2016) Oral anticoagulation and the risk of stroke or death in patients with atrial fibrillation and one additional stroke risk factor \u2013 the Loire valley atrial fibrillation project. Chest 149(4):960\u2013968","journal-title":"Chest"},{"issue":"38","key":"239_CR6","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D et\u00a0al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC Endorsed by the European Stroke Organisation (ESO). Eur Heart\u00a0J 37(38):2893\u20132962","journal-title":"Eur Heart J"},{"key":"239_CR7","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1001\/jama.2015.4369","volume":"313","author":"GYH Lip","year":"2015","unstructured":"Lip GYH, Lane DA (2015) Stroke prevention in atrial fibrillation. JAMA 313:1950\u20131962","journal-title":"JAMA"},{"issue":"11","key":"239_CR8","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s00392-016-0999-4","volume":"105","author":"M Proietti","year":"2016","unstructured":"Proietti M, Nobili A, Raparelli V, REPOSI investigators et\u00a0al (2016) Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study. Clin Res Cardiol 105(11):912\u2013920","journal-title":"Clin Res Cardiol"},{"key":"239_CR9","doi-asserted-by":"crossref","first-page":"h7013","DOI":"10.1136\/bmj.h7013","volume":"352","author":"CA Emdin","year":"2016","unstructured":"Emdin CA, Wong CX, Hsiao AJ et al (2016) Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ 352:h7013","journal-title":"BMJ"},{"key":"239_CR10","doi-asserted-by":"crossref","first-page":"e003074","DOI":"10.1161\/JAHA.115.003074","volume":"5","author":"X Yao","year":"2016","unstructured":"Yao X, Abraham NS, Alexander C et\u00a0al (2016) Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation. J\u00a0Am Heart Assoc 5:e003074","journal-title":"J Am Heart Assoc"},{"key":"239_CR11","doi-asserted-by":"crossref","first-page":"i2607","DOI":"10.1136\/bmj.i2607","volume":"353","author":"SV Wang","year":"2016","unstructured":"Wang SV, Franklin JM, Glynn RJ et\u00a0al (2016) Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study. BMJ 353:i2607","journal-title":"BMJ"},{"key":"239_CR12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.amjmed.2010.05.007","volume":"124","author":"GYH Lip","year":"2011","unstructured":"Lip GYH (2011) Implications of the CHA2DS2-VASc and HAS-BLED Scores for Thromboprophylaxis in Atrial Fibrillation. Am J Med 124:111\u2013114","journal-title":"Am J Med"},{"issue":"2","key":"239_CR13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"GYG Lip","year":"2011","unstructured":"Lip GYG, Frison L, Halperin JL, Lane DA (2011) Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation \u2013 the HAS-BLED (hypertension, abnormal renal\/liver function, stroke, bleeding history of predisposition, labile INR, elderly, drugs\/alcohol concomitantly) score. J\u00a0Am Coll Cardiol 57(2):173\u2013180","journal-title":"J Am Coll Cardiol"},{"key":"239_CR14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/HPC.0000000000000017","volume":"13","author":"AS Berger","year":"2014","unstructured":"Berger AS, Dunn AS, Kelley AS (2014) A standardized bleeding risk score aligns anticoagulation choices with current evidence. Crit Pathw Cardiol 13:109\u2013113","journal-title":"Crit Pathw Cardiol"},{"issue":"10","key":"239_CR15","first-page":"74","volume":"50","author":"Arzneimittelbrief","year":"2016","unstructured":"Arzneimittelbrief (2016) Blutungsrisiko von hochbetagten Patienten bei Therapie mit Vitamin-K-Antagonisten. Arzneimittelbrief 50(10):74\u201376","journal-title":"Arzneimittelbrief"},{"issue":"8","key":"239_CR16","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/jamainternmed.2016.3057","volume":"176","author":"HA Kooistra","year":"2016","unstructured":"Kooistra HA, Calf AH, Piersma-Wichers M et al (2016) Risk of bleeding and thrombosis in patients 70 years or older using vitamin K antagonists. JAMA Intern Med 176(8):1176\u20131183","journal-title":"JAMA Intern Med"},{"key":"239_CR17","unstructured":"Preuss R, Chenot J\u2011F, Angelow A (2016) Quality of care in patients with atrial fibrillation in primary care: a\u00a0cross-sectional study comparing clinical and claims data. GMS Ger Med Sci 14:Doc13.eCollection 2016"},{"key":"239_CR18","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","volume":"34","author":"R Chowdhury","year":"2013","unstructured":"Chowdhury R, Khan H, Heydon E et al (2013) Adherence to cardiovascular therapy: a\u00a0meta-analysis of prevalence and clinical consequences. Eur Heart\u00a0J 34:2940\u20132948","journal-title":"Eur Heart J"},{"key":"239_CR19","unstructured":"(2017) Cholesterin, der gro\u00dfe Bluff? In: Sprechstunde: Patienten fragen - \u00c4rzte antworten. Herz Heute 1\/2017:39\u201340"},{"issue":"25)(suppl 2","key":"239_CR20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","volume":"129","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH et\u00a0al (2014) 2013 ACC\/AHA guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a\u00a0report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 129(25)(suppl 2):S1\u2013S45","journal-title":"Circulation"},{"issue":"38","key":"239_CR21","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","volume":"34","author":"G Montalescot","year":"2013","unstructured":"Montalescot G, Sechtem U, Achenbach S et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart\u00a0J 34(38):2949\u20133003 (Erratum in 2014;35(33):2260-2261)","journal-title":"Eur Heart J"},{"key":"239_CR22","volume-title":"Nationale VersorgungsLeitlinie Chronische KHK \u2013 Langfassung 4.\u00a0Auflage Version 1","author":"Bundes\u00e4rztekammer (B\u00c4K)","year":"2016","unstructured":"Bundes\u00e4rztekammer (B\u00c4K), Kassen\u00e4rztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2016) Nationale VersorgungsLeitlinie Chronische KHK \u2013 Langfassung 4.\u00a0Auflage Version\u00a01. \n                        www.khk.Versorgungsleitlinien.de\n                        \n                    . Zugegriffen: 03.05.2017"},{"issue":"39","key":"239_CR23","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G et\u00a0al (2016) 2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart\u00a0J 37(39):2999\u20133058","journal-title":"Eur Heart J"},{"key":"239_CR24","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/eurheartj\/ehw046","volume":"37","author":"PM Ridker","year":"2016","unstructured":"Ridker PM, Mora S, Rose L, JUPITER Trial Study Group (2016) Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid- lowering agents. Eur Heart\u00a0J 37:1373\u20131379","journal-title":"Eur Heart J"},{"issue":"12","key":"239_CR25","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","volume":"316","author":"MG Silverman","year":"2016","unstructured":"Silverman MG, Ference BA, Im K et al (2016) Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions \u2013 a systematic review and meta-analysis. JAMA 316(12):1289\u20131297","journal-title":"JAMA"},{"key":"239_CR26","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/eurheartj\/ehw007","volume":"37","author":"AN Ganesan","year":"2016","unstructured":"Ganesan AN, Chew DP, Hartshorne T et al (2016) The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a\u00a0systematic review and meta-analysis. Eur Heart\u00a0J 37:1591\u20131602","journal-title":"Eur Heart J"},{"issue":"9753","key":"239_CR27","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"Cholesterol Treatment Trialists\u2018 (CTT) Collaboration","year":"2010","unstructured":"Cholesterol Treatment Trialists\u2018 (CTT) Collaboration (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a\u00a0meta-analysis of data from 170000 participants in 26 randomised trial. Lancet 376(9753):1670\u20131681","journal-title":"Lancet"},{"issue":"19","key":"239_CR28","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.2015.15629","volume":"316","author":"R Chou","year":"2016","unstructured":"Chou R, Dana T, Blazina I et\u00a0al (2016) Statins for prevention of cardiovascular disease in adults \u2013 evidence report and systematic review for the US preventive service task force. JAMA 316(19):2008\u20132024","journal-title":"JAMA"},{"issue":"10059","key":"239_CR29","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","volume":"388","author":"R Collins","year":"2016","unstructured":"Collins R, Reith C, Emberson J et\u00a0al (2016) Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 388(10059):2532\u20132561","journal-title":"Lancet"},{"issue":"21","key":"239_CR30","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMe1603504","volume":"374","author":"WC Cushman","year":"2016","unstructured":"Cushman WC, Goff DC (2016) More HOPE for Prevention with Statins (2016). N\u00a0Engl J Med 374(21):2085\u20132087","journal-title":"N Engl J Med"},{"issue":"3","key":"239_CR31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1056\/NEJMms1314569","volume":"370","author":"JF Keaney","year":"2014","unstructured":"Keaney JF, Curfman GD, Jarcho JA (2014) A pragmatic view of the new cholesterol treatment guidelines. N\u00a0Engl J Med 370(3):275\u2013278","journal-title":"N Engl J Med"},{"issue":"12","key":"239_CR32","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s00108-016-0155-2","volume":"57","author":"W Koenig","year":"2016","unstructured":"Koenig W, Nitschmann S (2016) Pr\u00e4vention kardiovaskul\u00e4rer Ereignisse \u2013 Heart Outcomes Prevention Evaluation (HOPE). Internist 57(12):1250\u20131253","journal-title":"Internist"},{"issue":"21","key":"239_CR33","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","volume":"374","author":"S Yusuf","year":"2016","unstructured":"Yusuf S, Bosch J, Dagenais G, HOPE-3 Investigators et al (2016) Cholesterol lowering in intermediate-risk persons without cardiovascular disease. N\u00a0Engl J Med 374(21):2021\u20132031","journal-title":"N Engl J Med"},{"issue":"1","key":"239_CR34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00392-016-1023-8","volume":"106","author":"MC Stam-Slob","year":"2017","unstructured":"Stam-Slob MC, Visseren FLJ, Jukema JW et al (2017) Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients. Clin Res Cardiol 106(1):58\u201368","journal-title":"Clin Res Cardiol"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-017-0239-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-017-0239-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-017-0239-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T13:08:38Z","timestamp":1496236118000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-017-0239-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["239"],"URL":"https:\/\/doi.org\/10.1007\/s00108-017-0239-7","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,11]]}}}